ZNF837
gene geneOn this page
Summary
ZNF837 (zinc finger protein 837, HGNC:25164) is a protein-coding gene on chromosome 19q13.43, encoding Zinc finger protein 837 (Q96EG3). May be involved in transcriptional regulation.
Enables identical protein binding activity. Predicted to be involved in regulation of transcription by RNA polymerase II. Predicted to be active in nucleus.
Source: NCBI Gene 116412 — RefSeq curated summary.
At a glance
- MANE Select transcript:
NM_138466
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:25164 |
| Approved symbol | ZNF837 |
| Name | zinc finger protein 837 |
| Location | 19q13.43 |
| Locus type | gene with protein product |
| Status | Approved |
| Ensembl gene | ENSG00000152475 |
| Ensembl biotype | protein_coding |
| Entrez | 116412 |
Gene structure
Transcript identifiers
Ensembl transcripts: 7 — 7 protein_coding
ENST00000427624, ENST00000597582, ENST00000851403, ENST00000851404, ENST00000851405, ENST00000851406, ENST00000923608
RefSeq mRNA: 1 — MANE Select: NM_138466
NM_138466
CCDS: CCDS46216
Canonical transcript exons
ENST00000597582 — 3 exons
| Exon | Start | End |
|---|---|---|
| ENSE00003058273 | 58369819 | 58369928 |
| ENSE00003189223 | 58367623 | 58369361 |
| ENSE00003199590 | 58380941 | 58381030 |
Expression profiles
Bgee: expression breadth ubiquitous, 151 present calls, max score 77.26.
FANTOM5 (CAGE): breadth broad, TPM avg 1.2389 / max 23.8964, expressed in 764 samples.
FANTOM5 promoters (1 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 182955 | 1.2389 | 764 |
Top tissues by expression
246 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| right uterine tube | UBERON:0001302 | 77.26 | gold quality |
| right lobe of liver | UBERON:0001114 | 71.78 | gold quality |
| left lobe of thyroid gland | UBERON:0001120 | 69.30 | gold quality |
| right lobe of thyroid gland | UBERON:0001119 | 69.19 | gold quality |
| stromal cell of endometrium | CL:0002255 | 68.58 | gold quality |
| metanephros cortex | UBERON:0010533 | 68.28 | gold quality |
| left ovary | UBERON:0002119 | 67.94 | gold quality |
| right ovary | UBERON:0002118 | 67.49 | gold quality |
| right adrenal gland | UBERON:0001233 | 67.44 | gold quality |
| right adrenal gland cortex | UBERON:0035827 | 67.30 | gold quality |
| thyroid gland | UBERON:0002046 | 67.28 | gold quality |
| left adrenal gland | UBERON:0001234 | 67.12 | gold quality |
| lower esophagus mucosa | UBERON:0035834 | 66.71 | gold quality |
| olfactory segment of nasal mucosa | UBERON:0005386 | 66.70 | gold quality |
| mucosa of transverse colon | UBERON:0004991 | 66.66 | gold quality |
| body of uterus | UBERON:0009853 | 66.58 | gold quality |
| left adrenal gland cortex | UBERON:0035825 | 66.56 | gold quality |
| ventricular zone | UBERON:0003053 | 66.55 | gold quality |
| skin of leg | UBERON:0001511 | 66.51 | gold quality |
| skin of abdomen | UBERON:0001416 | 66.40 | gold quality |
| left uterine tube | UBERON:0001303 | 66.18 | gold quality |
| endocervix | UBERON:0000458 | 66.01 | gold quality |
| granulocyte | CL:0000094 | 65.29 | gold quality |
| body of stomach | UBERON:0001161 | 65.13 | gold quality |
| body of pancreas | UBERON:0001150 | 65.03 | gold quality |
| adrenal cortex | UBERON:0001235 | 64.87 | gold quality |
| adenohypophysis | UBERON:0002196 | 64.79 | gold quality |
| ganglionic eminence | UBERON:0004023 | 64.62 | gold quality |
| ectocervix | UBERON:0012249 | 64.42 | gold quality |
| minor salivary gland | UBERON:0001830 | 64.27 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 1.07 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
7 targeting ZNF837, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-520D-5P | 99.98 | 73.34 | 4883 |
| HSA-MIR-524-5P | 99.98 | 73.43 | 4882 |
| HSA-MIR-520G-3P | 98.91 | 67.38 | 1914 |
| HSA-MIR-520H | 98.91 | 67.38 | 1914 |
| HSA-MIR-6769B-5P | 98.73 | 64.91 | 1092 |
| HSA-MIR-6769A-5P | 97.99 | 64.16 | 851 |
| HSA-MIR-4497 | 92.25 | 64.06 | 134 |
Cross-species orthologs
5 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | zfx | ENSDARG00000074453 |
| danio_rerio | ENSDARG00000098424 | |
| mus_musculus | Zfy2 | ENSMUSG00000000103 |
| mus_musculus | Zfy1 | ENSMUSG00000053211 |
| rattus_norvegicus | Zfy1 | ENSRNOG00000053042 |
Paralogs (38): ZFX (ENSG00000005889), ZBTB11 (ENSG00000066422), ZFAT (ENSG00000066827), ZFY (ENSG00000067646), ZNF586 (ENSG00000083828), IKZF5 (ENSG00000095574), ZNF419 (ENSG00000105136), ZNF549 (ENSG00000121406), ZSCAN20 (ENSG00000121903), ZNF304 (ENSG00000131845), PRDM15 (ENSG00000141956), ZNF660 (ENSG00000144792), ZNF711 (ENSG00000147180), ZNF773 (ENSG00000152439), ZNF256 (ENSG00000152454), ZNF691 (ENSG00000164011), ZNF610 (ENSG00000167554), E4F1 (ENSG00000167967), ZNF562 (ENSG00000171466), ZNF561 (ENSG00000171469), ZNF584 (ENSG00000171574), ZIK1 (ENSG00000171649), ZNF570 (ENSG00000171827), ZSCAN2 (ENSG00000176371), ZNF552 (ENSG00000178935), ZNF154 (ENSG00000179909), ZNF792 (ENSG00000180884), ZNF793 (ENSG00000188227), ZNF548 (ENSG00000188785), ZNF79 (ENSG00000196152), ZNF418 (ENSG00000196724), ZNF772 (ENSG00000197128), ZNF583 (ENSG00000198440), ZNF480 (ENSG00000198464), ZNF551 (ENSG00000204519), ZNF134 (ENSG00000213762), ZNF587B (ENSG00000269343), ZNF8 (ENSG00000278129)
Protein
Protein identifiers
Zinc finger protein 837 — Q96EG3 (reviewed: Q96EG3)
All UniProt accessions (1): Q96EG3
UniProt curated annotations — full annotation on UniProt →
Function. May be involved in transcriptional regulation.
Subcellular location. Nucleus.
Similarity. Belongs to the krueppel C2H2-type zinc-finger protein family.
RefSeq proteins (1): NP_612475* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR013087 | Znf_C2H2_type | Domain |
| IPR036236 | Znf_C2H2_sf | Homologous_superfamily |
Pfam: PF00096
UniProt features (13 total): zinc finger region 8, sequence variant 2, chain 1, compositionally biased region 1, region of interest 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q96EG3-F1 | 58.92 | 0.02 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 27 (showing top):
GOMF_SEQUENCE_SPECIFIC_DNA_BINDING, MODULE_49, ZWANG_TRANSIENTLY_UP_BY_2ND_EGF_PULSE_ONLY, GOMF_TRANSCRIPTION_REGULATOR_ACTIVITY, ASH1L_TARGET_GENES, CEBPZ_TARGET_GENES, ELF2_TARGET_GENES, FOXJ2_TARGET_GENES, HOXB7_TARGET_GENES, NAB2_TARGET_GENES, PRKDC_TARGET_GENES, RBM34_TARGET_GENES, MIR520G_3P_MIR520H, BLANCO_MELO_HUMAN_PARAINFLUENZA_VIRUS_3_INFECTION_A594_CELLS_DN, EWSR1_TARGET_GENES
GO Biological Process (1): regulation of transcription by RNA polymerase II (GO:0006357)
GO Molecular Function (7): RNA polymerase II cis-regulatory region sequence-specific DNA binding (GO:0000978), DNA-binding transcription factor activity, RNA polymerase II-specific (GO:0000981), zinc ion binding (GO:0008270), identical protein binding (GO:0042802), DNA binding (GO:0003677), protein binding (GO:0005515), metal ion binding (GO:0046872)
GO Cellular Component (1): nucleus (GO:0005634)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| RNA polymerase II transcription regulatory region sequence-specific DNA binding | 2 |
| regulation of DNA-templated transcription | 1 |
| transcription by RNA polymerase II | 1 |
| cis-regulatory region sequence-specific DNA binding | 1 |
| chromatin | 1 |
| DNA-binding transcription factor activity | 1 |
| regulation of transcription by RNA polymerase II | 1 |
| transition metal ion binding | 1 |
| protein binding | 1 |
| nucleic acid binding | 1 |
| binding | 1 |
| cation binding | 1 |
| intracellular membrane-bounded organelle | 1 |
Protein interactions and networks
STRING
394 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| ZNF837 | WDR97 | A6NE52 | 549 |
| ZNF837 | LRRC24 | Q50LG9 | 469 |
| ZNF837 | TEX14 | Q8IWB6 | 446 |
| ZNF837 | RFPL2 | O75678 | 413 |
| ZNF837 | SHROOM1 | Q2M3G4 | 393 |
| ZNF837 | GTF2IRD2B | Q6EKJ0 | 370 |
| ZNF837 | GTF2IRD2 | Q86UP8 | 368 |
| ZNF837 | VPS37B | Q9H9H4 | 359 |
| ZNF837 | RUSC1 | Q9BVN2 | 350 |
| ZNF837 | MRPL23 | Q16540 | 349 |
| ZNF837 | GET1 | O00258 | 303 |
| ZNF837 | ZFTA | C9JLR9 | 295 |
| ZNF837 | ADAMTS10 | Q9H324 | 254 |
| ZNF837 | RYR1 | P21817 | 253 |
| ZNF837 | CYTH2 | Q99418 | 251 |
IntAct
257 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| ZNF837 | ZNF317 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZNF837 | BEGAIN | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZNF837 | VASN | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZNF837 | ZNF121 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZNF837 | UBE2I | psi-mi:“MI:0915”(physical association) | 0.560 |
| TNS2 | ZNF837 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZNF124 | ZNF837 | psi-mi:“MI:0915”(physical association) | 0.560 |
| VASN | ZNF837 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZNF837 | psi-mi:“MI:0915”(physical association) | 0.560 | |
| PHF19 | ZNF837 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZNF837 | ZNF835 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZNF837 | CHIC2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| CYSRT1 | ZNF837 | psi-mi:“MI:0915”(physical association) | 0.560 |
| SPRED2 | ZNF837 | psi-mi:“MI:0915”(physical association) | 0.560 |
| MYO15B | ZNF837 | psi-mi:“MI:0915”(physical association) | 0.560 |
| CCNDBP1 | ZNF837 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZNF837 | ZNF837 | psi-mi:“MI:0915”(physical association) | 0.560 |
| BAHD1 | ZNF837 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZNF837 | ZNF330 | psi-mi:“MI:0915”(physical association) | 0.560 |
| FSD2 | ZNF837 | psi-mi:“MI:0915”(physical association) | 0.560 |
| KRTAP10-9 | ZNF837 | psi-mi:“MI:0915”(physical association) | 0.560 |
| KRTAP5-9 | ZNF837 | psi-mi:“MI:0915”(physical association) | 0.560 |
| CCDC125 | ZNF837 | psi-mi:“MI:0915”(physical association) | 0.560 |
BioGRID (79): ZNF837 (Two-hybrid), ZNF837 (Two-hybrid), ZNF837 (Two-hybrid), ZNF837 (Two-hybrid), ZNF837 (Two-hybrid), ZNF837 (Two-hybrid), ZNF837 (Two-hybrid), ZNF837 (Two-hybrid), ZNF837 (Two-hybrid), ZNF837 (Two-hybrid), ZNF837 (Two-hybrid), ZNF837 (Two-hybrid), ZNF837 (Two-hybrid), ZNF837 (Two-hybrid), ZNF837 (Two-hybrid)
ESM2 similar proteins: A6NM28, A6QPT6, A8K8V0, B2KFW1, E9PYI1, O14771, O60304, O75467, O95201, P10075, P10078, P10754, P17098, P28698, P30373, P59923, Q14929, Q16587, Q3KNW1, Q3URR7, Q4KLI1, Q58DK7, Q5RJR4, Q5T619, Q62396, Q68H95, Q6AW86, Q6PGE4, Q6ZMS7, Q6ZMY9, Q7Z398, Q7Z7K2, Q86UQ0, Q8BGS3, Q8BI73, Q8BZ34, Q8JZL0, Q8N393, Q91VW9, Q969J2
Diamond homologs: A0A9P4XV22, A2ANX9, B1H2Q6, O62836, P08048, P0CJ78, P10925, P17010, P17012, P20662, P27705, P28698, P52288, P80944, Q01611, Q03081, Q03125, Q0VDT2, Q29419, Q3U3I9, Q52V16, Q567C6, Q5U2Z0, Q6B4Z5, Q7RTV3, Q95LI3, Q966L8, Q96EG3, Q9UDV6, Q9UL36, Q9Y462, P17041, P18732, Q08AN1, Q3US17, Q80V23, Q86T29, Q8CF60, Q8TBZ5, Q96BV0
SIGNOR signaling
0 interactions.
Enriched among interaction partners
Reactome pathways and GO biological processes over-represented among this gene’s 77 IntAct physical interaction partners (hypergeometric vs the genome-wide background, BH-FDR, gene-set size 15–500, ranked by fold). A functional readout of the neighbourhood — distinct from this gene’s own memberships above, and biased toward well-studied / hub proteins, so read it as themes rather than proof.
Reactome pathways:
| Pathway | Partners | Fold | FDR |
|---|---|---|---|
| Keratinization | 9 | 12.5× | 3e-06 |
Disease & clinical
Clinical variants and AI predictions
ClinVar
0 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 0 |
| Likely benign | 0 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
329 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 19:58380939:A:AC | donor_gain | 1.0000 |
| 19:58380940:C:CC | donor_gain | 1.0000 |
| 19:58380940:CT:C | donor_gain | 1.0000 |
| 19:58380940:CTCT:C | donor_gain | 1.0000 |
| 19:58369358:GGAT:G | acceptor_gain | 0.9900 |
| 19:58369359:GAT:G | acceptor_gain | 0.9900 |
| 19:58369361:TC:T | acceptor_loss | 0.9900 |
| 19:58369362:C:CC | acceptor_gain | 0.9900 |
| 19:58369362:CT:C | acceptor_loss | 0.9900 |
| 19:58369363:T:C | acceptor_loss | 0.9900 |
| 19:58369715:A:AC | donor_gain | 0.9900 |
| 19:58369715:ACT:A | donor_gain | 0.9900 |
| 19:58369716:C:CC | donor_gain | 0.9900 |
| 19:58369716:CTC:C | donor_gain | 0.9900 |
| 19:58369716:CT:C | donor_gain | 0.9800 |
| 19:58380934:CACTT:C | donor_loss | 0.9800 |
| 19:58380935:ACTTA:A | donor_loss | 0.9800 |
| 19:58380937:TTA:T | donor_loss | 0.9800 |
| 19:58380938:TA:T | donor_loss | 0.9800 |
| 19:58380939:ACT:A | donor_gain | 0.9800 |
| 19:58380940:CTC:C | donor_gain | 0.9800 |
| 19:58369357:AGGAT:A | acceptor_gain | 0.9700 |
| 19:58369372:A:T | acceptor_gain | 0.9700 |
| 19:58369926:CAT:C | acceptor_gain | 0.9700 |
| 19:58369929:C:CC | acceptor_gain | 0.9700 |
| 19:58380933:CCACT:C | donor_loss | 0.9700 |
| 19:58380939:ACTCT:A | donor_gain | 0.9700 |
| 19:58380940:CTCTC:C | donor_gain | 0.9700 |
| 19:58369360:AT:A | acceptor_gain | 0.9600 |
| 19:58369371:C:CT | acceptor_gain | 0.9600 |
AlphaMissense
3400 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 19:58367797:G:C | F512L | 1.000 |
| 19:58367797:G:T | F512L | 1.000 |
| 19:58367799:A:G | F512L | 1.000 |
| 19:58367881:G:C | F484L | 0.999 |
| 19:58367881:G:T | F484L | 0.999 |
| 19:58367883:A:G | F484L | 0.999 |
| 19:58367965:G:C | F456L | 0.999 |
| 19:58367965:G:T | F456L | 0.999 |
| 19:58367967:A:G | F456L | 0.999 |
| 19:58368133:G:C | F400L | 0.999 |
| 19:58368133:G:T | F400L | 0.999 |
| 19:58368135:A:G | F400L | 0.999 |
| 19:58368217:G:C | F372L | 0.999 |
| 19:58368217:G:T | F372L | 0.999 |
| 19:58368219:A:G | F372L | 0.999 |
| 19:58368409:G:C | F308L | 0.999 |
| 19:58368409:G:T | F308L | 0.999 |
| 19:58368411:A:G | F308L | 0.999 |
| 19:58368493:G:C | F280L | 0.999 |
| 19:58368493:G:T | F280L | 0.999 |
| 19:58368495:A:G | F280L | 0.999 |
| 19:58367798:A:G | F512S | 0.998 |
| 19:58367854:G:C | H493Q | 0.998 |
| 19:58367854:G:T | H493Q | 0.998 |
| 19:58367842:G:C | H497Q | 0.997 |
| 19:58367842:G:T | H497Q | 0.997 |
| 19:58367856:G:C | H493D | 0.997 |
| 19:58367856:G:T | H493N | 0.997 |
| 19:58367882:A:G | F484S | 0.997 |
| 19:58367883:A:T | F484I | 0.997 |
dbSNP variants (sampled 300 via entrez): RS1000096586 (19:58381908 T>A), RS1000539931 (19:58371164 C>A), RS1000550874 (19:58381168 A>C), RS1000596390 (19:58376354 C>G), RS1000642632 (19:58370328 C>T), RS1000739533 (19:58367336 A>G), RS1000918224 (19:58367502 G>A,C), RS1001142254 (19:58371440 T>C), RS1001267225 (19:58374728 G>A), RS1001393585 (19:58368703 G>A,C,T), RS1001424853 (19:58368975 G>A,T), RS1001485720 (19:58381056 A>C), RS1001548030 (19:58382917 G>A), RS1001678494 (19:58380776 C>G,T), RS1001743360 (19:58369950 G>A)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
22 total (human), top 22 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Valproic Acid | affects cotreatment, decreases expression, increases methylation | 3 |
| (+)-JQ1 compound | increases expression | 2 |
| Particulate Matter | increases abundance, increases expression | 2 |
| GSK-J4 | decreases expression | 1 |
| OTX015 | increases expression | 1 |
| mivebresib | increases expression | 1 |
| methylmercuric chloride | decreases expression | 1 |
| beta-lapachone | decreases expression | 1 |
| ferrous chloride | decreases expression | 1 |
| di-n-butylphosphoric acid | affects expression | 1 |
| 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | affects cotreatment, decreases expression | 1 |
| dorsomorphin | affects cotreatment, decreases expression | 1 |
| Sunitinib | increases expression | 1 |
| Air Pollutants | increases abundance, increases expression | 1 |
| Arsenic | affects methylation | 1 |
| Vehicle Emissions | increases abundance, increases expression | 1 |
| Benzo(a)pyrene | affects methylation, increases methylation | 1 |
| Dichlorodiphenyl Dichloroethylene | decreases expression | 1 |
| Estradiol | decreases expression | 1 |
| Smoke | decreases expression | 1 |
| Tobacco Smoke Pollution | decreases expression | 1 |
| Okadaic Acid | decreases expression | 1 |
Cellosaurus cell lines
1 cell lines: 1 transformed cell line
First 10 cell lines (id-ordered, not curated):
| Cellosaurus | Name | Category | Sex |
|---|---|---|---|
| CVCL_HD46 | HEK293 eGFP-ZNF837 | Transformed cell line | Female |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.